Search PubMed⌕ Search

Biomedical subjects

A Carrassi

Publications and source records attributed to A Carrassi.

At least 19 recordsLinked to original sources
PubMed2000

Micro-morphometric assessment of titanium plasma-sprayed coating removal using burs for the treatment of peri-implant disease.

This study evaluated, in vitro, the effectiveness of diamond and carbide burs, and bur sequences to remove the plasma-sprayed titanium coating from IMZ fixture surfaces. Fifteen polishing procedures were tested. They included the use of 12, 16, 30 bladed carbide burs or bevered carbide burs and 30, 15, 8 microns mean-particles-size diamond burs. The treated surfaces were evaluated with profilometer and SEM. Worn burs and titanium debris produced by the grinding were observed with SEM. All procedures produce smoother surfaces than baseline plasma-sprayed surfaces for both Ra and Rz(DIN) parameters (P < 0.001). A roughening effect of the 8 microns mean-grit diamond bur and 30 bladed burs were noted. The single carbide burs produce polished surfaces affected by waviness. Waviness was minimized by sequence or diamond bur use. The carbide bur blades were variously damaged after their use. In contrast, the grit of diamond burs was observed to be clogged by titanium debris whose amount seemed to be inversely related to the diamond mean particle size. Debris produced by diamond burs was granular whereas that produced by carbide bladed burs showed needle or flake morphology. In conclusion, the most effective titanium plasma sprayed removal were obtained by 30 microns and 15 microns mean-particle-size diamond burs, i.e. 30 microns plus 15 microns diamond burs and carbide 12 plus 16 bladed burs used in sequence.

Analysis of Variance↗
PubMed1999

Benzydamine hydrochloride oral rinses in management of burning mouth syndrome. A clinical trial.

OBJECTIVE: The purpose of this study was to evaluate the efficacy of the topical use of benzydamine hydrochloride 0.15% oral mouthwashes in the control of burning mouth syndrome symptoms. STUDY DESIGN: In this double-blind, randomized, longitudinal investigation, each of 30 patients with burning mouth syndrome was assigned to one of 3 management modalities. Those in group A received an oral rinse solution of benzydamine hydrochloride 0.15% 3 times a day for 4 weeks, those in group B received a placebo 3 times a day for 4 weeks, and those in group C did not receive any kind of treatment. A visual analog scale was used for evaluation of the symptoms; a Kruskal-Wallis analysis of variance exact test was performed on the resulting data. RESULTS: The findings of this investigation failed to reveal significant differences among the groups. CONCLUSIONS: The clinical application of benzydamine hydrochloride oral rinses in the treatment of patients with burning mouth syndrome did not demonstrate significative efficacy in comparison with use of a placebo solution.

Administration, Topical↗
PubMed1999

GM-CSF mouthrinses in the treatment of severe oral mucositis: a pilot study.

OBJECTIVE: The aim of this open trial was to test the efficacy of granulocyte-macrophage colony-stimulating factor (GM-CSF) mouthrinses as a potential treatment in reducing the duration of severe oral mucositis in patients undergoing bone marrow transplantation for hematologic malignancies. STUDY DESIGN: The study group was composed of 10 consecutive patients suffering from severe oral mucositis during bone marrow transplantation procedures. The control group was similar to the study group in age and gender and comprised 29 historical patients with similar clinical characteristics. Freshly prepared GM-CSF mouthwash (0.5 microg/mL) was administered to the study population for 1 minute 3 times per day after oral hygiene procedures, starting from the first day of mucositis until clinical improvement of oral lesions. The study and control populations were compared with respect to duration of severe oral mucositis (1-9 days, 10-19 days, > or =20 days). RESULTS: There was no statistically (chi2 exact test) significant difference in mean mucositis score between the study group (11.9+/-6.1) and the control group (16.6+/-8.9). However, the duration of severe mucositis appeared to be reduced; 60% of the GM-CSF mouthrinse patients had severe mucositis for less than 9 days, whereas only 28% of the controls had severe mucositis for less than 9 days. In addition, 10% of the GM-CSF mouthrinse patients experienced severe mucositis lasting 20 or more days, whereas 34% of the controls experienced severe mucositis for 20 or more days. CONCLUSIONS: These findings suggest that GM-CSF may reduce the duration of severe mucositis, but controlled, double-blind clinical trials are now required.

Adolescent↗
PubMed1999

Hepatitis G virus: relevance to oral health care.

OBJECTIVE: To review the current literature on the hepatitis G virus (HGV) infection, with particular attention to the aspects of interest for the dental staff. MATERIAL AND METHODS: The authors searched for original research and review articles on specific aspects of the HGV infection including virology, epidemiology, transmission, natural history, and dental zaspects of HGV infection. The relevant articles were evaluated and reviewed. RESULTS: HGV is a parenterally transmitted RNA virus that may cause acute, chronic, and fulminant liver disease; however, the real pathogenic potential of this virus and its possible effect on other hepatitic infections is still to be clarified. Preliminary studies have failed to demonstrate strong relationships between HGV infection and any oral disease. At present, data on the prevalence of HGV infection among health care workers are scarce. Nevertheless, in view of the potential transmission rates of HGV and the lack of effective immunization, HGV should be regarded as a potential occupational hazard for medical and dental staff. CONCLUSION: Many virological, medical, and oral aspects of HGV infection need to be further investigated; nevertheless, until related data are available, HGV should be considered to be an infection that may be transmitted during dental care.

Animals↗
PubMed1998

Gingival lesions in a patient with dermochondrocorneal dystrophy (François syndrome). A case report.

This report is concerned with gingival manifestations associated with a case of dermochondrocorneal dystrophy (DCCD) or François syndrome occurring in a 42-year-old woman. Our Department treated this patient for 15 years. Oral examination of this case revealed a diffuse enlargement and severe inflammation of the attached gingiva. Systemic findings were similar to those reported in the literature for patients with DCCD. Firm papules 3 mm wide, localized on the face and on the dorsal surface of the hands, were associated with corneal involvement and progressive and severe articular disorder. Because they recurred after surgical ablation, the gingival lesions became an important problem in the management of the patient. After 10 years of unsuccessful treatment limited to scaling, oral hygiene control and mouth rinses with 0.2% chlorexidine solution, the patient was submitted to extraction of the remaining teeth, remodelling osteoplasty and cutaneous graft. An acrylic full denture was inserted. In a follow-up of 7 years, good results for the oral health of the patient were seen.

Adult↗
PubMed1998

Efficacy of topical mesalazine compared with clobetasol propionate in treatment of symptomatic oral lichen planus.

OBJECTIVE: To compare topically applied mesalazine (5-aminosalicylic acid) to topically applied clobetasol propionate in the treatment of patients suffering from symptomatic oral lichen planus. DESIGN: Randomized controlled longitudinal investigation. PATIENTS AND METHODS: Twenty-five out-patients suffering from oral lichen planus and referred to the Department of Oral Pathology and Oral Medicine of the University of Milan, Italy, during the period January to August 1997. Patients were randomly allocated (Group A and Group B) to treatment with mesalazine 5% or clobetasol propionate 0.05%. The drugs were topically applied twice daily for 4 weeks. Discomfort and pain were evaluated by the patient before and after treatment using a Visual Analogue Scale from zero (no pain) to 10 (extreme pain). Results were statistically evaluated by a Mann-Whitney U test. RESULTS: The two pharmacological regimens obtained partial and complete absence of symptoms. In particular, the mesalazine tested group disclosed 57% complete absence of symptoms, 21.3% partial response and 9% no response. No statistically relevant difference has been detected between the two regimens. CONCLUSIONS: The results of this preliminary study, if confirmed by further investigations, suggest that mesalazine might be considered an alternative to clobetasol propionate for treatment of symptomatic oral lichen planus.

Administration, Topical↗
PubMed1997

Attitude towards smoking and oral cancer prevention among northern Italian dentists.

The aim of the study was to evaluate the smoking habits of Northern Italian dental practitioners and their basic skills in the prevention of oral cancer. 217 of the 250 dental practitioners (86.8%) contacted by telephone from September to December 1994, answered a simple questionnaire. One third of the sample interviewed was formed by current smokers; nevertheless 60.8% of them always advise their patients to give up smoking. Only a relatively small percentage of the questioned dental practitioners (10.6%) do not examine the oral mucosa of the patients on a regular basis and 40% of responders had made a clinical diagnosis of oral cancer in the past. The lack of a specific dental education was associated with less scrupulous examination of the oral soft tissues and minor experience of cancer diagnosis. Despite their smoking habit, Northern Italian dental practitioners self-reported encouraging behaviour towards primary and secondary oral cancer prevention.

Adult↗
PubMed1997

Local antimicrobial therapy of oral mucositis in paediatric patients undergoing bone marrow transplantation.

The present investigation has examined the clinical benefits of tobramycin, polymyxin E and amphotericin therapy in the management of oral mucositis in children undergoing chemotherapy prior to bone marrow transplantation. Tobramycin, polymyxin E, and amphotericin reduced the degree of oral mucositis more than conventional therapy of diphenhydramine, Maalox, and local analgesic. While there was a statistically significant fall in the severity of the mucositis with tobramycin, polymyxin E and amphotericin, this was unlikely to be of practical benefit.

Adolescent↗
PubMed1997

The effect of surface roughness on early in vivo plaque colonization on titanium.

THE STUDY ASSESSES IN VIVO the surface roughness necessary to reduce plaque colonization on titanium after 24 hours. Three groups of 16 titanium disks were assigned to 3 different polishing groups (A, B, and C). The roughness was evaluated with a laser profilometer and the morphology with a scanning electron microscope (SEM). Eight volunteers were enrolled and two stents were applied in the mandibular posterior region of each. Each stent supported 3 disks, one per group. The volunteers suspended oral hygiene for 24 hours, after which the stents were removed; one was processed for evaluation of the adherent biomass and the other for SEM study. On each specimen a global area of 100 x 125 microns was examined with SEM. The area was composed of five 20 x 25 microns randomly selected fields. For each field the density of bacteria and the morphotypes were recorded. The data quoted for the global area are cumulative of those observed in the 20 x 25 microns fields. Group A had a significantly smoother surface than groups B and C. The adherent microbial biomass determination and SEM evaluation revealed that group A contained less bacteria than the roughest group. The bacterial population was composed of cocci in group A, and of cocci and short and long rods in groups B and C. We conclude that a titanium surface with Ra < or = 0.088 microns and Rz < or = 1.027 microns strongly inhibits accumulation and maturation of plaque at the 24-hour time period and that such smoothness can be achieved in transgingival and healing implant components.

Analysis of Variance↗
PubMed1996

Prevalence of oral lesions in inflammatory bowel disease.

OBJECTIVE: To obtain precise data on the prevalence of oral lesions in inflammatory bowel disease (IBD). METHODS: Oral lesions were carefully sought in a consecutive series of 198 Italian IBD outpatients, 77 with Crohn's disease (CD) and 121 with ulcerative colitis (UC); 89 subjects with functional intestinal motility disorders served as controls. RESULTS: The oral lesions detected were angular cheilitis (in 7.8% of CD patients, 5% of UC patients, and 0% of controls (p < 0.05, patients vs controls), lichen (6.5, 5.8, and 3.3%, respectively, p = not significant), aphthous ulcers (5.2, 5.8, and 5.6%, respectively, p = not significant), candidiasis (5.2, 0.8, and 0%, respectively, p < 0.05, CD patients vs controls), benign tumors (5.2, 0, and 7.8%, respectively, p < 0.05, patients vs controls), leukoplakia (5.2, 11, and 3.3%, respectively, p = not significant), and, less frequently, glossitis and herpes labialis. No specific CD oral lesions were observed in this series. No correlation was found between clinical disease activity and frequency of oral lesions. CONCLUSIONS: Aphthous ulcers are not common in IBD patients. Oral candidiasis is more frequent in CD than UC patients and controls.

Adolescent↗
PubMed1996

[Hepatitis C and dentistry. Review of the literature].

In 1988 the RNA virus responsible for the majority of cases of parenteral non A, non B hepatitis (NANBH) was isolated and designated Hepatitis C Virus (HCV). Since then, the sequence of the genome of the virus has been defined and at least 10 different types identified. Clinical studies indicate that the majority of patients who acquire HCV develop chronic hepatic disease, in particular chronic active hepatitis or cirrhosis and some of them will develop hepatocellular carcinoma. Currently, there is no effective anti-HCV therapy and no passive or active immunization protocol for HCV. Epidemiological studies indicate that HCV infection is relatively well confined to specific patient populations, in particular injecting drug users and recipients of blood and blood products. Nevertheless as HCV infection is transmitted mainly parenterally it must be regarded as a potential hazard for dental health care staff. This article reviews current knowledge concerning HCV infection with particular attention to those issues relevant to the dentists in Italy including the dental management of the HCV infected patient and the risk of HCV cross-infection in the dental environment.

Female↗
PubMed1995

Ultrastructure of hypersensitive and non-sensitive dentine. A study on replica models.

Patients with cervical dentine exposures do not always complain of dentine hypersensitivity. The identification of morphological features connected to symptoms is important for both prevention and management of dentine hypersensitivity. The aim of the study was to determine the relationship between the dentine ultrastructure and clinical symptoms in patients with cervical dentine exposures. Replica models for a total of 28 teeth (from 10 patients) with cervical non caroius lesions and dentine exposures were obtained before and after acid etching. The replica models were studied blindly in the scanning electron microscope (SEM). 12 of these were classified clinically as hypersensitive and 16 as non-sensitive. Because of the morphological heterogeneity of all specimens, a grid was used to isolate smaller, more homogeneous areas. 120 (75 non-sensitive and 45 hypersensitive areas) grid areas randomly selected from the 28 dentine surfaces were analyzed. The presence and morphology (amorphous or crystalline) of smear layers and the density and diameter of dentine tubules were recorded. The chi 2 test was used for statistical analysis. In unetched specimens, the surfaces classified as non-sensitive were frequently coated by an amorphous smear layer (88.0%) and occasionally by a crystalline smear layer (2.7%). Only a few and narrow tubules were observed (9.3%). On the other hand, the unetched specimens of the hypersensitive dentine exhibited less frequently (31.3%) an amorphous smear layer. The presence of crystalline smear layer (33.3%), many and wider patent tubules and, sometimes, loss of intertubular dentine manifested as grooves between tubules, were observed (35.6%). The differences were significant (p < .001). In hypersensitive dentine, the acid etching always removed the smear layer whereas removal in non-sensitive dentine was partial or absent. These morphological findings underline the rôle of smear layer in reducing permeability of dentine in patients with dentine sensitivity.

Acid Etching, Dental↗
PubMed1992

Prevention of local relapses and new localisations of oral leukoplakias with the synthetic retinoid fenretinide (4-HPR). Preliminary results.

This paper analyses preliminary results of a randomised chemoprevention trial in patients surgically treated for oral leukoplakia started in 1988 at the Istituto Nazionale Tumori of Milan with the synthetic retinoid N-(4-hydroxyphenyl)-retinamide (4-HPR). To date 115 patients have been randomised, after surgical excision of oral leukoplakia, to receive 200 mg 4-HPR daily for 52 weeks versus no intervention. 80 patients completed the 1-year intervention, 41 in the control group and 39 in the 4-HPR group. During this period 12 local relapses or new lesions occurred in the control group and three in the 4-HPR group. Only 5 patients interrupted the intervention because of toxicity. No impaired dark adaptation was observed. It is concluded that 4-HPR is well tolerated and seems efficacious in preventing relapses and new localisations during the treatment period. This promising trend needs further confirmation.

Adult↗
PubMed1991

[An assessment of the proliferative activity in oral lichen planus].

The author's aim was to evaluate the cell proliferation of oral lichen planus, by an in vitro labelling technique using tritiated thymidine (TLI). For this purpose six patients with oral lichen planus and six control volunteers with oral mucosa clinically sound were studied. The cell kinetic parameter was investigated by counting cells from autoradiographs on histological sections of the biopsies. Significant differences were found between the basal TLI of the two group (p = 0.002) but no between the epithelial TLI (Wilcoxon test).

Biopsy↗
PubMed1990

[Study of cellular kinetics in oral leukoplakia].

The Authors aim was to study the Labeling Indices (LI) of 12 subjects with oral leukoplakia, using an in vitro labeling technique with tritiated thymidine (Silvestrini-Kit, Ribbon spa, Milan). Twelve volunteers of our Dental Clinic were enrolled in this study as a control group. The kinetic parameter was investigated by counting cells from autoradiographs on histological selections of the biopsies. By a Wilcoxon test, significant differences were found between the LI of the two groups: p = 0.00003. Finally, a comparison has also been made between LI of these lesions and the LI of oral squamous cell carcinomas.

Adult↗